Literature DB >> 24770627

Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.

Angela Henderson-Redmond1, Cristine Czachowski.   

Abstract

The endogenous opioid system has been implicated in mediating the reinforcing effects of ethanol (EtOH). Naltrexone (NTX), an opioid antagonist with concentration-dependent selectivity for the mu receptor, naltrindole (NTI), a selective delta receptor antagonist, and U50,488H, a selective kappa receptor agonist were examined in both alcohol-preferring (P) and nonselected (Long Evans (LE)) rats to determine whether they differentially affected the seeking and consumption of EtOH and sucrose. Using the sipper-tube model, rats reinforced with either 2% sucrose or 10% EtOH were injected with vehicle and either NTI (2.5, 5.0, or 10.0 mg/kg), U50 (2.5, 5.0, or 10.0 mg/kg), low-dose NTX (0.1, 0.3, or 1.0 mg/kg), or high-dose NTX (1.0, 3.0, or 10.0 mg/kg). Subsequent intakes (consummatory) or lever responses (seeking) were assessed. Overall, NTI, U50, and NTX attenuated intake and responding for sucrose and EtOH, with EtOH-reinforced P rats being the most sensitive to the effects of NTI on intake and seeking. U50 treatment decreased intake and seeking in both P and LE rats but did not selectively reduce EtOH intake or seeking in either line. P rats were more sensitive than LE rats to lower doses of NTX, and these doses more selectively attenuated responding for EtOH than sucrose. Higher doses of NTX suppressed intake and responding across both lines and reinforcers. These results suggest that drugs selective for the opioid receptors may be good pharmacotherapeutic targets, particularly in those with an underlying genetic predisposition for greater EtOH preference/intake.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24770627      PMCID: PMC4209193          DOI: 10.1007/s00213-014-3571-9

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  70 in total

1.  Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa.

Authors:  M A Marrazzi; J P Bacon; J Kinzie; E D Luby
Journal:  Int Clin Psychopharmacol       Date:  1995-09       Impact factor: 1.659

2.  Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence.

Authors:  A C King; J R Volpicelli; A Frazer; C P O'Brien
Journal:  Psychopharmacology (Berl)       Date:  1997-01       Impact factor: 4.530

3.  Alcohol drinking is reduced by a mu 1- but not by a delta-opioid receptor antagonist in alcohol-preferring rats.

Authors:  A Honkanen; L Vilamo; K Wegelius; M Sarviharju; P Hyytiä; E R Korpi
Journal:  Eur J Pharmacol       Date:  1996-05-23       Impact factor: 4.432

4.  Involvement of mu-opioid receptors in alcohol drinking by alcohol-preferring AA rats.

Authors:  P Hyytiä
Journal:  Pharmacol Biochem Behav       Date:  1993-07       Impact factor: 3.533

5.  The delta 2-opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference.

Authors:  S Krishnan-Sarin; P S Portoghese; T K Li; J C Froehlich
Journal:  Pharmacol Biochem Behav       Date:  1995-09       Impact factor: 3.533

6.  The influence of opioid antagonists on the discriminative stimulus effects of ethanol.

Authors:  R Spanagel
Journal:  Pharmacol Biochem Behav       Date:  1996-08       Impact factor: 3.533

7.  Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants.

Authors:  F Weiss; M T Lorang; F E Bloom; G F Koob
Journal:  J Pharmacol Exp Ther       Date:  1993-10       Impact factor: 4.030

Review 8.  Naltrexone in the treatment of alcoholism: a clinical review.

Authors:  C P O'Brien; L A Volpicelli; J R Volpicelli
Journal:  Alcohol       Date:  1996 Jan-Feb       Impact factor: 2.405

9.  The effects of selective blockade of delta and mu opiate receptors on ethanol consumption by C57BL/6 mice in a restricted access paradigm.

Authors:  A D Lê; C X Poulos; B Quan; S Chow
Journal:  Brain Res       Date:  1993-12-10       Impact factor: 3.252

10.  The delta opioid receptor antagonist naltrindole attenuates both alcohol and saccharin intake in rats selectively bred for alcohol preference.

Authors:  S Krishnan-Sarin; S L Jing; D L Kurtz; M Zweifel; P S Portoghese; T K Li; J C Froehlich
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

View more
  23 in total

1.  Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

Authors:  Yan Zhou; Rachel Saylor Crowley; Konrad Ben; Thomas E Prisinzano; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2017-03-02       Impact factor: 3.252

2.  Caenorhabditis elegans as a model system to identify therapeutics for alcohol use disorders.

Authors:  Simon N Katner; Kristin E Bredhold; Kevin B Steagall; Richard L Bell; Bethany S Neal-Beliveau; Mi C Cheong; Eric A Engleman
Journal:  Behav Brain Res       Date:  2019-02-22       Impact factor: 3.332

3.  The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeking.

Authors:  Chiara Giuliano; Charles R Goodlett; Daina Economidou; Maria P García-Pardo; David Belin; Trevor W Robbins; Edward T Bullmore; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2015-06-05       Impact factor: 7.853

4.  Orexin/hypocretin-1 receptor antagonism reduces ethanol self-administration and reinstatement selectively in highly-motivated rats.

Authors:  David E Moorman; Morgan H James; Elisabeth A Kilroy; Gary Aston-Jones
Journal:  Brain Res       Date:  2016-10-19       Impact factor: 3.252

Review 5.  Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

Authors:  Rachel I Anderson; Howard C Becker
Journal:  Alcohol Clin Exp Res       Date:  2017-06-05       Impact factor: 3.455

Review 6.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

7.  Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.

Authors:  Terril L Verplaetse; Cristine L Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

8.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

9.  The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.

Authors:  Amy W M Ewald; Peter J Bosch; Aimee Culverhouse; Rachel Saylor Crowley; Benjamin Neuenswander; Thomas E Prisinzano; Bronwyn M Kivell
Journal:  Psychopharmacology (Berl)       Date:  2017-05-23       Impact factor: 4.530

10.  Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.

Authors:  András Váradi; Gina F Marrone; Shainnel O Eans; Michelle L Ganno; Joan J Subrath; Valerie Le Rouzic; Amanda Hunkele; Gavril W Pasternak; Jay P McLaughlin; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-09-14       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.